share_log

康希諾生物：內幕消息 - 一致行動人的權益變動

CANSINOBIO: INSIDE INFORMATION - CHANGE OF INTERESTS OF PARTIES ACTING IN CONCERT

HKEX ·  Dec 13 21:05

Summary by Moomoo AI

康希諾生物宣佈董事會成員變動及股權結構調整。自2024年3月27日起，于玉、邱東旭及毛慧華將不再擔任公司董事職務，其任期將於2024年7月24日屆滿。公司股權結構也將發生變化，控股股東持股比例從31.29%降至28.07%。具體而言，于玉、邱東旭及毛慧華個人持股比例分別為7.26%、6.92%和6.60%，保持不變。然而，公司員工持股計劃所持有的3.23%股份將被撤銷。值得注意的是，毛慧華通過CHAMPDEN LLC和Medicharms LLC間接持有額外股份。此外，趙守白作為毛慧華的配偶，持有0.02%的公司股份。康希諾生物成立於2009年1月13日，于玉、邱東旭及毛慧華自2017年2月13日起擔任公司董事。公司於2018年5月24日在香港聯交所上市，股票代碼為06185。截至公告日期，于玉仍擔任公司CEO職務。這次董事會成員變動和股權結構調整可能對公司未來發展策略產生影響。
康希諾生物宣佈董事會成員變動及股權結構調整。自2024年3月27日起，于玉、邱東旭及毛慧華將不再擔任公司董事職務，其任期將於2024年7月24日屆滿。公司股權結構也將發生變化，控股股東持股比例從31.29%降至28.07%。具體而言，于玉、邱東旭及毛慧華個人持股比例分別為7.26%、6.92%和6.60%，保持不變。然而，公司員工持股計劃所持有的3.23%股份將被撤銷。值得注意的是，毛慧華通過CHAMPDEN LLC和Medicharms LLC間接持有額外股份。此外，趙守白作為毛慧華的配偶，持有0.02%的公司股份。康希諾生物成立於2009年1月13日，于玉、邱東旭及毛慧華自2017年2月13日起擔任公司董事。公司於2018年5月24日在香港聯交所上市，股票代碼為06185。截至公告日期，于玉仍擔任公司CEO職務。這次董事會成員變動和股權結構調整可能對公司未來發展策略產生影響。
CANSINOBIO announced changes in the Board of Directors members and jiegoutiaozheng. Starting from March 27, 2024, Yu Yu, Qiu Dongxu, and Mao Huihua will no longer serve as directors of the company, and their terms will expire on July 24, 2024. The company’s Shareholder Holdings will also change, with the controlling shareholder's holdings decreasing from 31.29% to 28.07%.Specifically, the personal shareholding ratios of Yu Yu, Qiu Dongxu, and Mao Huihua remain at 7.26%, 6.92%, and 6.60%, respectively. However, the 3.23% shares held by the company’s employee stock ownership plan will be canceled. It is worth noting that Mao Huihua indirectly holds additional shares through CHAMPDEN LLC and Medicharms LLC. In addition, Zhao Shoubai, as Mao Huihua's spouse, holds 0.02% of the company's shares.CANSINOBIO was...Show More
CANSINOBIO announced changes in the Board of Directors members and jiegoutiaozheng. Starting from March 27, 2024, Yu Yu, Qiu Dongxu, and Mao Huihua will no longer serve as directors of the company, and their terms will expire on July 24, 2024. The company’s Shareholder Holdings will also change, with the controlling shareholder's holdings decreasing from 31.29% to 28.07%.Specifically, the personal shareholding ratios of Yu Yu, Qiu Dongxu, and Mao Huihua remain at 7.26%, 6.92%, and 6.60%, respectively. However, the 3.23% shares held by the company’s employee stock ownership plan will be canceled. It is worth noting that Mao Huihua indirectly holds additional shares through CHAMPDEN LLC and Medicharms LLC. In addition, Zhao Shoubai, as Mao Huihua's spouse, holds 0.02% of the company's shares.CANSINOBIO was established on January 13, 2009, and Yu Yu, Qiu Dongxu, and Mao Huihua have served as directors since February 13, 2017. The company was listed on the Hong Kong Stock Exchange on May 24, 2018, with the stock code 06185. As of the announcement date, Yu Yu still holds the position of CEO of the company. This change in the Board of Directors and the jiegoutiaozheng may have an impact on the company's future development strategy.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated